REGULATION CF OFFERING
This Private Offering Memorandum (“Memorandum“) is intended solely for accredited investors and outlines an investment opportunity in Shapeaccelerator BV, a US/Dutch-managed international entity. The whole entity is a US/Dutch entity. The Capital is raised through the entity of choice depending on their preferred investment format. MRF Investments LLC- USA and MRF Investments BV – NL are the holding companies of the shares of both entities.
Shapeaccelerator BV is offering a private placement under the following four investment instruments
All investments are to be made by direct transfer to the following corporate account:
Funds raised from this offering will be utilized to:
This Memorandum does not purport to be all-inclusive or contain all the information a prospective investor may desire. Any representations or statements made herein are qualified in their entirety by the actual documents and agreements.
By accepting this Memorandum, the recipient agrees to keep its contents strictly confidential and to use the information solely for the purpose of evaluating an investment in Shapeaccelerator USA LLC or BV.
For Further Information, Please Contact:
Investor Relations
Etienne M.J.M. Hendrickx
etienne@shapeaccelerator.com
+31613736324
Shapeaccelerator USA LLC, as the distributor of the product, adheres to FDA listing requirements as mandated by applicable regulations. Shape Accelerator is manufactured in the United States at a facility registered with U.S. Good and Drug Administration (FDA). While we are actively in the process of obtaining FDA registration for Shape Accelerator products, it is important to note that our company also holds a Certificate of Cosmetic Product Listing, confirming compliance with the mandatory listing requirement for cosmetics. We are committed to transparency and regulatory compliance and will provide updates on our progress towards full FDA registration. For any inquiries regarding the regulatory status of our products, please feel free to contact us.